ArticleBioresources and bioprocessing2026
Sustainable carotenoid production using amylaceous agro-industrial byproducts: process efficiency and environmental assessment.
Article in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Agro‑industrial brans are abundant residues that can be valorized as low‑cost feedstocks for microbial bioprocesses within a circular‑economy framework. Here, we investigated the use of corn, soybean, rice and wheat bran hydrolysates as sole nutrient sources (no detoxification and no supplementation) for carotenoid production by the yeast Rhodotorula mucilaginosa. After standardizing total fermentable sugars to 10-12 g/L, the yeast successfully consumed mixed sugars and produced biomass and carotenoids in all hydrolysates. Rice bran hydrolysate led to the highest carotenoid titer (28.41 ± 0.23 mg/L) and the highest specific carotenoid content (1.11 ± 0.05 mg
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.